A critical advance in cancer study is arising with the use of mini-antibodies to reactivate mutated p53. This crucial tumor inhibitor protein is frequently inactivated in many forms of tumors, causing uncontrolled cell https://easiestbookmarks.com/story22062581/vhh-fragments-reactivate-p53-new-new-approach-for-malignant-management